Home → Guides → Vaccine fridge temperature excursion
Immunisation cold-chain guide

What to do when a vaccine fridge goes out of range

Protect stock, preserve the evidence, identify exactly which products were affected, obtain specialist and manufacturer advice, and decide separately whether stock can be used and whether patients who already received doses need any action. This is England immunisation guidance, and product-specific storage instructions and local commissioning arrangements take precedence for an actual incident.

A vaccine fridge alarm sounds or a daily check shows a temperature outside the expected range. Pause use of potentially affected stock while you establish what happened. Label and separate it so another member of staff cannot administer it by mistake. Keep it under suitable monitored storage conditions while the incident is assessed. The UKHSA: vaccine incident guidance gives a formal pathway for storage incidents.

Start by protecting stock and preserving evidence

Do not throw stock away immediately, reset the thermometer without recording its readings, or switch the fridge off before the cause and exposure history can be reconstructed. The common recommended storage range for many vaccines is +2°C to +8°C, but the product’s current instructions matter. The question is not simply whether a display showed 8.1°C. You need to know the duration, actual stock temperature, which products were present, their previous excursion history and whether any were already administered.

UKHSA says one-off rises above +8°C lasting less than 20 minutes during activities such as stock taking are unlikely to breach the cold chain and should be documented rather than treated as a major incident. That does not justify ignoring a prolonged or poorly understood breach, a freezing event or a product with different instructions. See UKHSA: vaccine incident guidance section 6.

A useful first response has two tracks. One person secures stock and records the fridge state. Another informs the local immunisation lead, pharmacy or named cold-chain lead under the service policy and checks whether anyone received affected stock. The team should make a simple time line before moving products or resetting alarms. If an alternate validated refrigerator is available, document the transfer conditions and location. Maintain a clear not for use status until the authorised clinical or immunisation decision is recorded.

Confirm whether the alarm represents a real stock exposure

Record the current temperature, displayed maximum and minimum, time of discovery, last acceptable reading, alarm history and any continuous data logger trace. Photograph the display if that helps preserve the evidence. Check whether the probe is correctly placed and whether the door was open for a short period. Do not assume that air temperature at the probe equals the temperature inside every vial. Equally, do not dismiss an alarm because the fridge is back within range when someone arrives. A loss of power overnight may have ended before the morning check.

UKHSA asks providers to investigate fridge and thermometer performance, current and previous readings, stock position, service history and cold-chain practice. Its storage incident algorithm says to keep the fridge switched on and avoid disturbing thermometers and probes while evidence is gathered. Where appropriate, an engineer should inspect the appliance and the temperature pattern should be checked. A display that was reset before anyone wrote down the maximum and minimum makes the risk assessment harder and may cause avoidable disposal.

Check the stock itself. Were boxes pushed against a cooling plate, back wall or air inlet? Was the fridge overfilled or recently restocked? Did a power cut, door left ajar, room heating failure or broken seal affect conditions? Was there visible freezing, condensation or damaged packaging? Which stock was on each shelf? The event may affect products differently. A short warm excursion can have a different effect from freezing, and a previous excursion can reduce the margin available for another. Manufacturers may have product-specific stability information that a generic fridge policy cannot supply.

Write down any uncertainty rather than inventing a precise duration. If the last recorded acceptable temperature was Friday afternoon and the problem was found on Monday morning, that is a possible exposure window, not proof that stock spent the entire weekend outside range. The data logger, alarm log, building power records and staff accounts may narrow it. If no reliable trace exists, the risk assessor must work with a conservative range of possibilities. The record should show how the estimate was made.

Separate and identify every affected product

Create an inventory with vaccine name, manufacturer, batch, expiry, presentation, quantity, location in the fridge and whether the product was already opened or reconstituted. Include diluents when their storage conditions are relevant. Record deliveries received during the possible excursion and any stock transferred out. Do not treat all products as a single vaccines line. Each product may have different stability data, and the same batch may have been stored in more than one place.

The UKHSA: Green Book chapter 3 explains the importance of keeping the cold chain and following manufacturer recommendations. UKHSA’s incident guidance applies a product-specific risk assessment and says to seek appropriate specialist and manufacturer advice. If a vaccine has a current product information document with a different storage range or in-use period, use that current product information. Seasonal and newly introduced products can change, so a static table in an article would be unsafe.

Keep the isolated stock in a controlled, monitored place. If the original fridge can maintain the recommended range and the cause has been corrected, the local policy may allow stock to remain there while embargoed. If it cannot, use a suitable alternative and record the transfer start, transport method, temperatures and receiving location. Preserve the incident label on every container. A casual move to an office fridge can create a second unknown exposure and destroy the evidence needed for a decision.

The person who inventories stock should also check whether any doses were administered after the earliest possible start of the incident. Use vaccine administration records, appointment times and batch traceability. That question should be answered early, but patient contact and revaccination decisions belong to a formal clinical risk process. Do not send a broad recall message merely because a fridge alarm occurred.

Make a documented product-specific risk assessment

The provider’s immunisation or clinical lead should assemble the temperature evidence, product inventory and circumstances of the breach. UKHSA says decisions about using stock after an excursion must be made case by case following a full risk assessment, including specialist advice from the local health protection team, screening and immunisation team and manufacturer as appropriate. The conclusion should account for stability information and the exposure pattern. See UKHSA: incident guidance section 7.3.

A risk assessment should answer several distinct questions. Did the stock genuinely leave its recommended conditions? Which product and batches were exposed? For how long, at what temperatures and after what prior excursions? Is there evidence of freezing, damage or loss of potency? What does the manufacturer advise for this exact product and presentation? Is the available evidence strong enough to support continued use, or must stock be discarded? Is a further clinical decision needed because some doses were already administered? Keep the advice from each source attached to the decision.

Do not use a blanket rule that every reading above +8°C means disposal. UKHSA notes that many vaccines tolerate some short excursions and that its disposal advice can be conservative when stability data are insufficient. Equally, do not infer that every vaccine is safe because some products tolerate a short warm exposure. A chilled product may be damaged by freezing or by a duration and temperature outside its evidence base. The decision needs product-specific support, not a generic calculator.

If stock remains suitable after assessment but use would be outside its licensed storage conditions, UKHSA describes it as off-label use. The clinical professionals who administer it should know that status, and the advice and conclusion should be documented. If stock is deemed unusable, dispose of it under local policy with batch and quantity recorded. The threshold for discarding stock is not automatically the threshold for revaccinating people who already received a dose. Those are separate judgements with different evidence and consequences.

If affected vaccines were already given

Escalate promptly through the local incident route. UKHSA says a formal incident control team should be established where compromised vaccines were administered or a large revaccination exercise is being considered. The team draws in the provider, screening and immunisation, health protection and clinical expertise. It determines whether doses were likely to have had reduced potency and what, if anything, patients need to be told or offered.

Trace doses by batch and time. Identify recipients of potentially affected stock while protecting their confidentiality. Verify the administration record before contacting anyone, because the same fridge may have held unaffected stock, and the possible exposure period may be narrower than first thought. The team should decide whether the patient needs no action, information and reassurance, further assessment or revaccination. A disposed batch does not automatically mean every recipient needs another dose. UKHSA explicitly distinguishes prospective stock disposal from retrospective clinical assessment.

Communications should be led by the incident team. Explain what is known, what remains uncertain and what action the patient should take. Check consent, duty of candour and records requirements under the actual circumstances. Document contact attempts and outcomes in the clinical system, not a general facilities tracker. If a patient receives a repeat dose, use current product and schedule guidance. Avoid drafting a generic all affected patients must be recalled message before the clinical team has decided who was affected and whether a repeat dose is indicated.

For an incident involving COVID-19 or another product with special handling and stability rules, obtain current product-specific advice. The UKHSA 2022 incident guidance itself warns that not every detail applies to coronavirus vaccines. Immunisation schedules and presentations change. At publication and at the point of incident, check the current programme guidance rather than assuming a 2022 example covers a 2026 product.

Restore the fridge without erasing the incident

Correct the cause of the excursion. That may mean repairing a seal, changing a loading practice, moving the probe, restoring power, adjusting an alarm response or replacing the fridge. An engineer’s repair note should state what was found, what was changed and what was tested. Confirm that the refrigerator can maintain appropriate temperatures before placing usable stock back into routine circulation. UKHSA’s algorithm calls for checking current temperature patterns with a data logger when appliance performance is in doubt.

Update the routine control system. Who checks minimum and maximum temperatures? Who resets the thermometer after recording? Who responds to an alarm outside opening hours? How does the team distinguish a brief door-opening fluctuation from sustained loss of control? What spare monitored storage exists during a breakdown? A policy that names no backup fridge or transfer route leaves staff improvising during the next event. The NHS England East of England: 2026 cold-chain policy provides a detailed regional incident checklist, but providers should follow their own current commissioned service arrangements and product requirements.

The event record should include the original readings, continuous trace, stock inventory, manufacturer and specialist advice, decision for each product, disposal or return to use, patient assessment if applicable, fridge repair and validation, and the prevention actions. Keep a clear distinction between fridge repaired and stock released. The device may be ready while stock remains quarantined for clinical review. Stock may be judged usable while the old fridge still needs replacement.

A review should ask why the event was detected when it was. Did the alarm work? Did the duty holder receive it? Was the fridge overfilled? Were data logger batteries flat? Were temperatures recorded in a way that made the duration knowable? Improving those controls prevents avoidable vaccine waste and reduces the chance that compromised stock is administered. Record actions with owners and dates, and verify that they worked at the next review.

Worked example: a brief door-open rise

A practice records a brief rise above +8°C while staff restock the fridge. The continuous trace shows a rise of less than 20 minutes and a return to normal. Staff record the cause, the maximum and minimum readings and the reset. UKHSA says a one-off rise of this kind is unlikely to have breached the cold chain and generally needs documentation rather than further action. The team still checks that no product-specific instruction changes the conclusion and that the trace is reliable.

The learning may be about workflow rather than stock. Can staff restock in smaller batches? Is the fridge door left open while boxes are counted? Does the alarm threshold or logging practice need review? A short harmless fluctuation can be a useful prompt to reduce future risk without creating an unnecessary stock embargo. The example does not authorise ignoring repeated brief rises or an unexplained alarm.

Worked example: overnight failure with vaccinations that morning

A practice finds the fridge warm after opening. The last manual acceptable reading was the previous afternoon, and the data logger stopped recording overnight. Staff isolate the vaccine stock, label it not for use and move it to a monitored alternative under the local plan. They preserve the original display and alarm information. The provider lists each product and batch, requests engineer and specialist advice, and reconstructs the possible temperature window from power records and staff observations.

Three vaccinations were given before the alarm was noticed. The clinical lead identifies those doses and informs the local incident route. The provider and specialist team assess stock viability and separately assess whether patients need any action. They do not assume that all three doses were ineffective merely because stock might be discarded. The fridge is repaired and its performance checked. Product decisions, patient decisions and fridge return to use are each signed off and recorded. The practice revises its out-of-hours alarm escalation so a similar fault can be detected earlier.

What Complys can support

A general compliance platform can help assign a fridge check owner, retain temperature logs, set service or calibration reminders and track corrective actions. It should not be described as making product-specific stock release decisions, replacing manufacturer advice, notifying patients or submitting an incident report unless those capabilities are verified. Keep clinical and batch records in systems with appropriate access control. Sensitive patient details do not belong in a generic equipment task.

A well-organised evidence trail makes a clinical decision auditable. It does not decide vaccine potency. The provider should compare any record, reminder and action workflow with its local vaccine incident policy before relying on it, and confirm the exact cold-chain features with a product specialist before assuming automated temperature monitoring or incident decisions.

A close-out checklist that reflects the real decisions

Before closing the event, can the service show the alarm and temperature history? Are all affected products and batches identified? Was stock physically separated and labelled during assessment? Did the appropriate clinical and specialist advisers review exposure and manufacturer data? Is there a recorded decision for each product, including off-label status where relevant? Were any administered doses traced and assessed through the right incident route? Is the fridge demonstrably stable again? Have the causes and alarm-response gaps been corrected? Can another clinician find the decision without relying on someone’s memory?

If the answer to a key question is no, the event needs more work. A single checkbox labelled cold chain resolved is too coarse. Stock status, appliance status and patient-impact status can move at different speeds. Keeping them separate protects patients and prevents usable stock from being discarded without assessment.

Questions people ask

Does every reading above +8°C mean the stock must be discarded?

No. UKHSA says decisions about using stock after an excursion must be made case by case following a full risk assessment, including specialist and manufacturer advice as appropriate. Many vaccines tolerate some short excursions, while disposal advice can be conservative when stability data are insufficient. A blanket rule in either direction is unsafe.

A brief rise happened while restocking. Is that a major incident?

Often not. UKHSA says a one-off rise above +8°C lasting less than 20 minutes during activities such as stock taking is unlikely to breach the cold chain and should be documented rather than treated as a major incident. Still check that no product-specific instruction changes the conclusion and that the temperature trace is reliable.

If affected doses were already given, does everyone need revaccination?

Not automatically. UKHSA distinguishes prospective stock disposal from retrospective clinical assessment. A formal incident team decides, from batch and time tracing, whether recipients need no action, information, further assessment or revaccination. A disposed batch does not by itself mean every recipient needs another dose.

Can Complys decide whether the vaccine is still usable?

No. Complys can assign a fridge-check owner, retain temperature logs, set calibration or service reminders and track corrective actions. It does not decide vaccine viability, replace manufacturer advice, notify patients or submit an incident report. The usability and quarantine decision stays with the manufacturer and the clinical or pharmacy lead.

Where Complys fits

Complys can log a temperature excursion, assign a fridge-check owner, retain temperature logs, set service or calibration reminders and track corrective actions to owners and dates. It does not monitor fridge temperatures continuously, analyse vaccine stability, decide viability, consult the manufacturer, recall batches or message patients. The quarantine and usability decision stays with the manufacturer and the clinical or pharmacy lead, and clinical and batch records belong in systems with appropriate access control.

Sources

Related: Complys for clinics, incident reporting software, and more compliance guides.